Neuroendocrine Determinants of Polycystic Ovary Syndrome

    March 2022 in “ International Journal of Environmental Research and Public Health ”
    Anna Szeliga, Ewa Rudnicka, Marzena Maciejewska-Jeske, Marek Kucharski, Anna Kostrzak, Marta Hajbos, Olga Niwczyk, Roman Smolarczyk, Błażej Męczekalski
    Image of study
    TLDR Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.
    The document discusses the role of neuroendocrine determinants in Polycystic Ovary Syndrome (PCOS), a common endocrine disorder in women. It highlights the role of neurohormones such as Gonadotropin-releasing hormone (GnRH), kisspeptin, and Neurokinin B (NKB), and neurotransmitters in the development of PCOS. The document reveals that women with PCOS have a persistent rapid GnRH pulse frequency and higher serum kisspeptin levels, suggesting overactivity in the kisspeptin system. This overactivity leads to hypothalamic-pituitary-gonadal axis overactivity, menstrual disorders, hyperandrogenemia, and hyperandrogenism. Abnormal regulation of NKB is also suspected to contribute to PCOS development. The document concludes that further studies are needed to fully understand the neuroendocrine mechanisms behind PCOS.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 19 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 3 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community C’est terrible - at my wits end

      in Female  450 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community PCOS Hair Loss: What’s Helped Me (and What Didn’t)

      in Treatment  11 upvotes 1 week ago
      OP shares their experience with PCOS-related hair loss, highlighting that addressing vitamin D and ferritin deficiencies, managing hormones with spironolactone, and using gentle hair care products helped improve their condition. They advise against relying on "miracle" hair oils and emphasize the importance of medical evaluation and a combined approach to treatment.

    Related Research

    1 / 1 results